← Back to Search

Vascular Rehabilitation and Follow Up for Peripheral Arterial Disease

N/A
Waitlist Available
Led By William P Shutze, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Enrolled in the vascular rehabilitation program at The Heart Hospital Cardiac Rehabilitation Facility.
Female or male patients ≥18 years of age.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 1 year after discharge
Awards & highlights

Study Summary

This trial is testing a rehabilitation program for people with vascular problems to see if it improves walking distance and quality of life.

Eligible Conditions
  • Peripheral Arterial Disease
  • Peripheral Vascular Disease
  • Vascular Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 1 year after discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1 year after discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in ankle brachial indices at baseline of VRP and at the termination of VRP (6-12 weeks) (ABI range 0-2)
Changes to quality of life surveys at VRP enrollment, VRP discharge, and one year after discharge. Range 7-175
Changes to total walking distance at VRP enrollment, VRP discharge, and at one year post discharge
+1 more
Secondary outcome measures
Determination of activity level evaluated on daily, weekly, monthly and cumulative levels
Rate of lower extremity revascularization intervention that occurs during the study period (1 year following program discharge).

Trial Design

1Treatment groups
Experimental Treatment
Group I: Vascular Rehabilitation and Follow UpExperimental Treatment1 Intervention
All subjects will be enrolled in a 6-12 Vascular Rehab Program (VRP) and then be followed for one year following discharge from the VRP.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
198 Previous Clinical Trials
202,745 Total Patients Enrolled
2 Trials studying Peripheral Arterial Disease
14,250 Patients Enrolled for Peripheral Arterial Disease
William P Shutze, MDPrincipal InvestigatorBaylor Scott & White Heart Hospital Plano

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~1 spots leftby Mar 2025